Skip to content
Saturday, November 14, 2026
Ultimate Royal Platform

Users Stopping Slimming Medications Regain Weight at a Quadrupled Rate Than Dieters

Image of pharmaceutical syringe and scale
Weight management often requires ongoing approaches.

Fresh analysis suggests that individuals who stop using popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who end conventional diet and exercise plans.

Published data in a prominent health publication demonstrates that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.

"People buying such medications must be cognizant of the danger of fast weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.

This pace of regain means a reversion to starting weight in about one and a half years.

Weighing Therapies

The analysis, which examined dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.

Scientists note that individuals who lose weight through dieting typically have a more gradual weight regain—perhaps 100 grams monthly—after stopping.

Explaining the Rapid Rebound

Nutrition scientists propose the mechanism of the injections accounts for the heightened weight return.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing GLP-1 levels several times higher than normal might result in the body to produce less of its own natural hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making overeating a significant risk."

An Ongoing Condition?

Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, due to the high risk of weight regain, the therapy might need to be life-long.

This view is supported by pharmaceutical companies, who say that the results "underscore the long-term nature of obesity," akin to managing diseases like high blood pressure.

User Accounts

People who have come off the medication describe a powerful return of hunger.

"It felt as if something flipping and I was suddenly extremely hungry," described an individual.

This challenge is worsened if individuals have not established permanent lifestyle or habit modifications during treatment.

Growing Use

Figures show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.

  • Adoption is more common among females compared to men.
  • The middle-aged demographic shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent fix and maintained weight loss relies on integrated behavioural management.

CW
About the author

Claudia Wood

A historian specializing in European monarchy with over a decade of research experience, passionate about uncovering untold royal stories.

Ultimate Royal Platform

Type to search articles.